Navigating Decisions in a New Treatment Era in HCC: Current Evidence, Key Trials, and Future Frontiers

In this online program based on a dynamic CCO symposium from the 2020 ASCO GI Symposium, experts discuss evidence-based best practices in treating patients with HCC. Watch the on-demand Webcast and download the slides now.
James M. Cleary, MD, PhD
Stacey Stein, MD
Andrew X. Zhu, MD, PhD, FACP

Downloadable Slidesets

Download this slideset for expert perspectives on the optimal use of systemic therapy in the first-line setting for patients with advanced HCC.

Stacey Stein, MD Released: January 23, 2020

Download this slideset for expert perspectives on current best practices and emerging strategies in immune checkpoint inhibitor therapy for patients with advanced HCC.

Andrew X. Zhu, MD, PhD, FACP Released: January 23, 2020

Download this slideset for expert perspectives on targeted systemic therapy for patients with advanced HCC who have failed an initial systemic regimen.

James M. Cleary, MD, PhD Released: January 23, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Eisai
Merck Sharp & Dohme Corp

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue